Literature DB >> 28912616

Decision making in neonatal end-of-life scenarios in low-income settings1.

James McTavish1.   

Abstract

The challenge of decision making in end-of-life scenarios is exacerbated when the patient is a newborn and in a low-income setting. The principle of proportionate care is a helpful guide but needs to be applied. The complex interplay of benefit, burden, and cost of various treatments all need to be considered. In patients with severe neonatal encephalopathy, prognosis can be hard to determine, and a team approach to decision making can help. In low-income settings, or where there are limited resources, the ideal care needs to be incarnated in the real context. Issues of social justice also arise as finite resources need to be used prudently.
SUMMARY: Decisions regarding medical care become difficult when the patient is a seriously ill newborn baby. In the developing world, scarce medical facilities and minimal economic resources also limit possible treatment options. The Catholic Church offers practical ethical principles which can help the medical team and family to strive to do what is morally best in these difficult situations.

Entities:  

Keywords:  Decision making; Neonatal encephalopathy; Newborn; Proportionate means; Social justice

Year:  2017        PMID: 28912616      PMCID: PMC5592305          DOI: 10.1080/00243639.2017.1300759

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  10 in total

1.  MRI and withdrawal of life support from newborn infants with hypoxic-ischemic encephalopathy.

Authors:  Dominic Wilkinson
Journal:  Pediatrics       Date:  2010-07-05       Impact factor: 7.124

2.  The Groningen protocol--euthanasia in severely ill newborns.

Authors:  Eduard Verhagen; Pieter J J Sauer
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

3.  The Catholic tradition on forgoing life support.

Authors:  Kevin D O'Rourke
Journal:  Natl Cathol Bioeth Q       Date:  2005

Review 4.  Cooling in a low-resource environment: lost in translation.

Authors:  Paolo Montaldo; Shreela S Pauliah; Peter J Lally; Linus Olson; Sudhin Thayyil
Journal:  Semin Fetal Neonatal Med       Date:  2014-10-31       Impact factor: 3.926

5.  Brain death declaration: Practices and perceptions worldwide.

Authors:  Sarah Wahlster; Eelco F M Wijdicks; Pratik V Patel; David M Greer; J Claude Hemphill; Marco Carone; Farrah J Mateen
Journal:  Neurology       Date:  2015-04-08       Impact factor: 9.910

Review 6.  Hypothermia and neonatal encephalopathy.

Authors:  Lu-Ann Papile; Jill E Baley; William Benitz; James Cummings; Waldemar A Carlo; Eric Eichenwald; Praveen Kumar; Richard A Polin; Rosemarie C Tan; Kasper S Wang
Journal:  Pediatrics       Date:  2014-06       Impact factor: 7.124

7.  Neonatal euthanasia: The Groningen Protocol.

Authors:  Felipe E Vizcarrondo
Journal:  Linacre Q       Date:  2014-11

8.  Follow-up of the term infant after hypoxic-ischemic encephalopathy.

Authors:  Charlene Mt Robertson; Max Perlman
Journal:  Paediatr Child Health       Date:  2006-05       Impact factor: 2.253

Review 9.  Hypothermia for perinatal brain hypoxia-ischemia in different resource settings: a systematic review.

Authors:  Tais F Galvao; Marcus T Silva; Mariana C Marques; Nelson D de Oliveira; Mauricio G Pereira
Journal:  J Trop Pediatr       Date:  2013-06-18       Impact factor: 1.165

Review 10.  Therapeutic hypothermia for neonatal encephalopathy in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Shreela S Pauliah; Seetha Shankaran; Angie Wade; Ernest B Cady; Sudhin Thayyil
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  10 in total
  2 in total

1.  Becoming Light of the World.

Authors:  James McTavish
Journal:  Linacre Q       Date:  2018-04-02

2.  Decision-making around resuscitation of extremely preterm infants in the Philippines: A consensus guideline.

Authors:  Dominic Jc Wilkinson; Maria Esterlita Villanueva-Uy; Dean Hayden; James McTavish
Journal:  J Paediatr Child Health       Date:  2019-07-25       Impact factor: 1.954

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.